packageMirdametinib

mirdametinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mirdametinib is a MEK inhibitor anticancer drug used to treat plexiform neurofibromas associated with neurofibromatosis type 1. It is an approved medicine, authorised in the European Union, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q27088255 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mirdametinib
ATC codes:L01EE05
DrugBank:DB07101
PubChem CID:9826528
ChEBI:88249
Wikidata:Q27088255
formula:C16H14F3IN2O4
molar mass:482.192 g/mol (PubChem CID 9826528)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown